Ardelyx (ARDX) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

ARDX Stock Forecast

Ardelyx stock forecast is as follows: an average price target of $11.00 (represents a 137.07% upside from ARDX’s last price of $4.64) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.

ARDX Price Target

The average price target for Ardelyx (ARDX) is $11.00 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $11.00 to $11.00. This represents a potential 137.07% upside from ARDX's last price of $4.64.

ARDX Analyst Ratings

Buy

According to 8 Wall Street analysts, Ardelyx's rating consensus is 'Buy'. The analyst rating breakdown for ARDX stock is 0 'Strong Buy' (0.00%), 7 'Buy' (87.50%), 1 'Hold' (12.50%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Ardelyx Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 05, 2024	Ed Arce	H.C. Wainwright	$11.00	$6.05	81.82%	137.07%
Jul 05, 2024	Ed Arce	H.C. Wainwright	$10.00	$5.29	89.04%	115.52%
May 24, 2024	Christopher Raymond	Raymond James	$15.00	$7.20	108.31%	223.28%
Dec 18, 2023	Ryan Deschner	Raymond James	$12.00	$6.30	90.33%	158.62%
Dec 30, 2022		Citigroup	$7.00	$2.85	145.61%	50.86%
Dec 29, 2022	Laura Chico	Wedbush	$2.00	$2.33	-14.35%	-56.90%

The latest Ardelyx stock forecast, released on Aug 05, 2024 by Ed Arce from H.C. Wainwright, set a price target of $11.00, which represents a 81.82% increase from the stock price at the time of the forecast ($6.05), and a 137.07% increase from ARDX last price ($4.64).

Ardelyx Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	3
Avg Price Target	-	-	$12.00
Last Closing Price	$4.64	$4.64	$4.64
Upside/Downside	-100.00%	-100.00%	158.62%

In the current month, the average price target of Ardelyx stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Ardelyx's last price of $4.64. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 05, 2024	H.C. Wainwright	Buy	Buy	Hold
Aug 02, 2024	Wedbush	Buy	Buy	Hold
Jul 05, 2024	H.C. Wainwright	Buy	Buy	Hold
Jul 02, 2024	Piper Sandler	Overweight	Neutral	Downgrade
Jun 20, 2024	Wedbush	Buy	Buy	Hold
May 24, 2024	Piper Sandler	Overweight	Overweight	Hold
May 24, 2024	Wedbush	Buy	Buy	Hold
May 03, 2024	Cowen & Co.	Buy	Buy	Hold
May 03, 2024	Citigroup	Buy	Buy	Hold
Apr 05, 2024	Wedbush	Buy	Buy	Hold
Feb 23, 2024	Wedbush	Buy	Buy	Hold
Jan 12, 2024	Wedbush	Outperform	Outperform	Hold
Jan 09, 2024	Wedbush	Strong Buy	Strong Buy	Hold
Aug 25, 2023	Cantor Fitzgerald		Overweight	Upgrade
Mar 03, 2023	Wedbush		Outperform	Upgrade
Dec 30, 2022	Citigroup	Buy	Buy	Hold
Dec 29, 2022	Piper Sandler	Overweight	Overweight	Hold
Nov 23, 2022	Sandler O'Neill		Overweight	Upgrade
Nov 17, 2022	Piper Sandler		Overweight	Upgrade
Mar 02, 2022	Jefferies		Buy	Upgrade

Ardelyx's last stock rating was published by H.C. Wainwright on Aug 05, 2024. The company gave ARDX a "Buy" rating, the same as its previous rate.

Ardelyx Financial Forecast

Ardelyx Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$56.39M	$22.33M	$11.37M	$44.18M	$4.99M	$2.53M	$468.00K	$1.03M	$1.17M	$1.31M	$6.58M	$1.81M	$2.71M	$1.84M	$1.21M	$2.25M	$3.01M
Avg Forecast	$181.50M	$172.00M	$164.50M	$157.00M	$110.73M	$101.97M	$93.02M	$83.32M	$108.56M	$86.64M	$55.03M	$36.40M	$34.06M	$22.57M	$15.28M	$10.41M	$23.18M	$3.92M	$2.22M	$875.00K	$875.50K	$1.32M	$940.00K	$1.38M	$1.66M	$1.36M	$1.81M	$550.00K	$975.00K	$150.00K
High Forecast	$243.40M	$230.66M	$220.60M	$210.54M	$148.49M	$136.74M	$124.74M	$123.96M	$125.56M	$86.84M	$55.03M	$36.40M	$37.65M	$24.09M	$20.49M	$13.95M	$31.08M	$3.92M	$2.22M	$875.00K	$875.50K	$1.32M	$940.00K	$1.38M	$1.66M	$1.36M	$1.81M	$550.00K	$975.00K	$150.00K
Low Forecast	$149.31M	$141.50M	$135.33M	$129.16M	$91.09M	$83.88M	$76.52M	$65.50M	$98.26M	$86.44M	$55.03M	$36.40M	$32.16M	$20.81M	$12.57M	$8.56M	$19.07M	$3.92M	$2.22M	$875.00K	$875.50K	$1.32M	$940.00K	$1.38M	$1.66M	$1.36M	$1.81M	$550.00K	$975.00K	$150.00K
# Analysts	3	3	3	3	4	4	4	6	8	4	4	4	5	7	6	3	2	2	2	2	3	4	5	6	6	8	8	9	12	7
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	2.50%	1.46%	1.09%	1.91%	1.27%	1.14%	0.53%	1.18%	0.89%	1.40%	4.79%	1.09%	2.00%	1.01%	2.21%	2.31%	20.09%

Ardelyx's average Quarter revenue forecast for Dec 23 based on 5 analysts is $34.06M, with a low forecast of $32.16M, and a high forecast of $37.65M. ARDX's average Quarter revenue forecast represents a -39.60% decrease compared to the company's last Quarter revenue of $56.39M (Sep 23).

Ardelyx EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	3	3	3	3	4	4	4	6	8	4	4	4	5	7	6	3	2	2	2	2	3	4	5	6	6	8	8	9	12	7
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$7.40M	$-16.62M	$-24.76M	$12.52M	$-20.55M	$-25.97M	$-27.09M	$-35.06M	$-41.91M	$-43.62M	$-31.63M	$-27.14M	$-16.47M	$-23.26M	$-20.52M	$-17.88M	$-21.16M
Avg Forecast	$-161.35M	$-152.90M	$-146.23M	$-139.57M	$-98.43M	$-90.64M	$-82.69M	$-74.07M	$-96.51M	$-77.02M	$-48.92M	$-45.32M	$-30.28M	$-20.06M	$-13.58M	$-35.83M	$-37.28M	$-3.49M	$-1.97M	$-28.32M	$-778.28K	$-1.17M	$-835.62K	$-30.67M	$-1.48M	$-1.21M	$-1.61M	$-20.52M	$-866.73K	$-133.34K
High Forecast	$-132.73M	$-125.78M	$-120.30M	$-114.81M	$-80.98M	$-74.57M	$-68.03M	$-58.23M	$-87.35M	$-76.84M	$-48.92M	$-36.26M	$-28.59M	$-18.50M	$-11.18M	$-28.66M	$-29.82M	$-3.49M	$-1.97M	$-22.66M	$-778.28K	$-1.17M	$-835.62K	$-24.54M	$-1.48M	$-1.21M	$-1.61M	$-16.42M	$-866.73K	$-133.34K
Low Forecast	$-216.37M	$-205.04M	$-196.10M	$-187.16M	$-132.00M	$-121.56M	$-110.89M	$-110.19M	$-111.62M	$-77.20M	$-48.92M	$-54.39M	$-33.47M	$-21.41M	$-18.22M	$-42.99M	$-44.73M	$-3.49M	$-1.97M	$-33.99M	$-778.28K	$-1.17M	$-835.62K	$-36.81M	$-1.48M	$-1.21M	$-1.61M	$-24.63M	$-866.73K	$-133.34K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.37%	1.22%	0.69%	-0.34%	5.89%	13.15%	0.96%	45.04%	35.79%	52.20%	1.03%	18.36%	13.63%	14.47%	1.00%	20.63%	158.65%

5 analysts predict ARDX's average Quarter EBITDA for Dec 23 to be $-30.28M, with a high of $-28.59M and a low of $-33.47M. This is -509.27% lower than Ardelyx's previous annual EBITDA (Sep 23) of $7.40M.

Ardelyx Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	3	3	3	3	4	4	4	6	8	4	4	4	5	7	6	3	2	2	2	2	3	4	5	6	6	8	8	9	12	7
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$6.63M	$-17.12M	$-26.77M	$10.70M	$-23.91M	$-26.94M	$-28.07M	$-37.22M	$-43.59M	$-45.19M	$-33.16M	$-28.88M	$-18.11M	$-24.96M	$-22.37M	$-19.79M	$-23.54M
Avg Forecast	$49.54M	$42.46M	$37.75M	$33.03M	$4.13M	$-2.77M	$-9.19M	$-18.83M	$1.25M	$-11.57M	$-25.01M	$-46.96M	$-22.34M	$-25.38M	$-27.20M	$-37.12M	$-38.53M	$-39.50M	$-45.18M	$-29.35M	$-71.26M	$-82.42M	$-85.71M	$-32.15M	$-61.28M	$-66.32M	$-62.75M	$-22.37M	$-76.20M	$-86.79M
High Forecast	$71.50M	$61.29M	$54.48M	$47.67M	$5.95M	$-2.13M	$-7.07M	$-9.16M	$4.99M	$-8.90M	$-19.24M	$-37.57M	$-9.93M	$-13.84M	$-20.93M	$-29.70M	$-30.82M	$-39.50M	$-45.18M	$-23.48M	$-71.26M	$-82.42M	$-85.71M	$-25.72M	$-61.28M	$-66.32M	$-62.75M	$-17.90M	$-76.20M	$-86.79M
Low Forecast	$38.12M	$32.67M	$29.04M	$25.41M	$3.17M	$-4.00M	$-13.26M	$-24.42M	$-4.99M	$-16.70M	$-36.10M	$-56.35M	$-27.30M	$-34.61M	$-39.25M	$-44.55M	$-46.23M	$-39.50M	$-45.18M	$-35.22M	$-71.26M	$-82.42M	$-85.71M	$-38.58M	$-61.28M	$-66.32M	$-62.75M	$-26.85M	$-76.20M	$-86.79M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.26%	0.63%	0.72%	-0.28%	0.61%	0.60%	0.96%	0.52%	0.53%	0.53%	1.03%	0.47%	0.27%	0.40%	1.00%	0.26%	0.27%

Ardelyx's average Quarter net income forecast for Dec 23 is $-22.34M, with a range of $-27.30M to $-9.93M. ARDX's average Quarter net income forecast represents a -436.95% decrease compared to the company's last Quarter net income of $6.63M (Sep 23).

Ardelyx SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	3	3	3	3	4	4	4	6	8	4	4	4	5	7	6	3	2	2	2	2	3	4	5	6	6	8	8	9	12	7
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$32.66M	$27.19M	$26.80M	$19.73M	$18.67M	$18.86M	$19.34M	$15.33M	$19.71M	$20.12M	$17.13M	$11.34M	$7.63M	$7.04M	$7.14M	$6.86M	$6.92M
Avg Forecast	$678.21M	$642.71M	$614.69M	$586.66M	$413.76M	$381.02M	$347.59M	$311.34M	$405.66M	$323.76M	$205.63M	$32.35M	$127.27M	$84.33M	$57.10M	$38.88M	$16.31M	$14.65M	$8.30M	$3.27M	$3.27M	$4.92M	$3.51M	$5.14M	$6.21M	$5.08M	$6.76M	$2.06M	$3.64M	$560.50K
High Forecast	$909.49M	$861.89M	$824.31M	$786.72M	$554.87M	$510.96M	$466.13M	$463.18M	$469.18M	$324.50M	$205.63M	$38.82M	$140.70M	$90.00M	$76.58M	$52.14M	$19.57M	$14.65M	$8.30M	$3.27M	$3.27M	$4.92M	$3.51M	$5.14M	$6.21M	$5.08M	$6.76M	$2.06M	$3.64M	$560.50K
Low Forecast	$557.93M	$528.73M	$505.67M	$482.62M	$340.38M	$313.45M	$285.95M	$244.75M	$367.16M	$323.01M	$205.63M	$25.88M	$120.17M	$77.78M	$46.98M	$31.99M	$13.04M	$14.65M	$8.30M	$3.27M	$3.27M	$4.92M	$3.51M	$5.14M	$6.21M	$5.08M	$6.76M	$2.06M	$3.64M	$560.50K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.39%	0.48%	0.69%	1.21%	1.27%	2.27%	5.91%	4.69%	4.01%	5.73%	3.33%	1.83%	1.50%	1.04%	3.47%	1.88%	12.35%

Ardelyx's average Quarter SG&A projection for Dec 23 is $127.27M, based on 5 Wall Street analysts, with a range of $120.17M to $140.70M. The forecast indicates a 289.64% rise compared to ARDX last annual SG&A of $32.66M (Sep 23).

Ardelyx EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	3	3	3	3	4	4	4	6	8	4	4	4	5	7	6	3	2	2	2	2	3	4	5	6	6	8	8	9	12	7
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$0.03	$-0.00	$-0.13	$0.06	$-0.14	$-0.19	$-0.21	$-0.32	$-0.42	$-0.45	$-0.34	$-0.32	$-0.20	$-0.28	$-0.25	$-0.27	$-0.37
Avg Forecast	$0.21	$0.18	$0.16	$0.14	$0.02	$-0.01	$-0.04	$-0.08	$0.01	$-0.05	$-0.11	$-0.15	$-0.09	$-0.11	$-0.12	$-0.10	-	$-0.17	$-0.19	$-0.22	$-0.30	$-0.35	$-0.37	$-0.33	$-0.26	$-0.28	$-0.27	$-0.25	$-0.32	$-0.37
High Forecast	$0.30	$0.26	$0.23	$0.20	$0.03	$-0.01	$-0.03	$-0.04	$0.02	$-0.04	$-0.08	$-0.11	$-0.04	$-0.06	$-0.09	$-0.08	-	$-0.17	$-0.19	$-0.22	$-0.30	$-0.35	$-0.37	$-0.33	$-0.26	$-0.28	$-0.27	$-0.25	$-0.32	$-0.37
Low Forecast	$0.16	$0.14	$0.12	$0.11	$0.01	$-0.02	$-0.06	$-0.10	$-0.02	$-0.07	$-0.15	$-0.21	$-0.12	$-0.15	$-0.17	$-0.15	-	$-0.17	$-0.19	$-0.22	$-0.30	$-0.35	$-0.37	$-0.33	$-0.26	$-0.28	$-0.27	$-0.25	$-0.32	$-0.37
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.28%	0.00%	1.29%	25.92%	0.83%	0.99%	0.95%	1.05%	1.20%	1.23%	1.03%	1.22%	0.71%	1.05%	1.00%	0.83%	1.00%

According to 5 Wall Street analysts, Ardelyx's projected average Quarter EPS for Dec 23 is $-0.09, with a low estimate of $-0.12 and a high estimate of $-0.04. This represents a -415.60% decrease compared to ARDX previous annual EPS of $0.03 (Sep 23).

Ardelyx Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
HEPA	Hepion Pharmaceuticals	$0.50	$70.00	13900.00%	Buy
LXRX	Lexicon Pharmaceuticals	$0.76	$6.00	689.47%	Buy
PDSB	PDS Bio	$1.64	$9.00	448.78%	Buy
INZY	Inozyme Pharma	$2.93	$16.00	446.08%	Buy
ZURA	Zura Bio	$2.32	$10.00	331.03%	Buy
TERN	Terns Pharmaceuticals	$5.80	$18.67	221.90%	Buy
IBRX	ImmunityBio	$2.63	$8.00	204.18%	Buy
ARDX	Ardelyx	$4.64	$11.00	137.07%	Buy
VSTM	Verastem	$3.90	$7.00	79.49%	Buy
MREO	Mereo BioPharma Group	$3.81	$6.75	77.17%	Buy
HOOK	HOOKIPA Pharma	$1.90	$3.00	57.89%	Buy
MCRB	Seres Therapeutics	$0.96	$1.25	30.21%	Buy

ARDX Forecast FAQ

Is Ardelyx a good buy?

Yes, according to 8 Wall Street analysts, Ardelyx (ARDX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 87.50% of ARDX's total ratings.

What is ARDX's price target?

Ardelyx (ARDX) average price target is $11 with a range of $11 to $11, implying a 137.07% from its last price of $4.64. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Ardelyx stock go up soon?

According to Wall Street analysts' prediction for ARDX stock, the company can go up by 137.07% (from the last price of $4.64 to the average price target of $11), up by 137.07% based on the highest stock price target, and up by 137.07% based on the lowest stock price target.

Can Ardelyx stock reach $7?

ARDX's average twelve months analyst stock price target of $11 supports the claim that Ardelyx can reach $7 in the near future.

What are Ardelyx's analysts' financial forecasts?

Ardelyx's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $389.04M (high $533.93M, low $317M), average EBITDA is $-346M (high $-282M, low $-475M), average net income is $-26.661M (high $-12.408M, low $-38.513M), average SG&A $1.45B (high $2B, low $1.18B), and average EPS is $-0.113 (high $-0.0526, low $-0.163). ARDX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $675M (high $905.19M, low $555.29M), average EBITDA is $-600M (high $-494M, low $-805M), average net income is $162.78M (high $234.94M, low $125.25M), average SG&A $2.52B (high $3.38B, low $2.07B), and average EPS is $0.69 (high $0.996, low $0.531).

Did the ARDX's actual financial results beat the analysts' financial forecasts?

Based on Ardelyx's last annual report (Dec 2022), the company's revenue was $52.16M, beating the average analysts forecast of $30.19M by 72.75%. Apple's EBITDA was $-62.126M, missing the average prediction of $-71.059M by -12.57%. The company's net income was $-67.207M, missing the average estimation of $-153M by -55.95%. Apple's SG&A was $76.6M, beating the average forecast of $42.53M by 80.11%. Lastly, the company's EPS was $-0.42, missing the average prediction of $-0.58 by -27.57%. In terms of the last quarterly report (Sep 2023), Ardelyx's revenue was $56.39M, beating the average analysts' forecast of $22.57M by 149.86%. The company's EBITDA was $7.4M, missing the average prediction of $-20.063M by -136.87%. Ardelyx's net income was $6.63M, missing the average estimation of $-25.379M by -126.12%. The company's SG&A was $32.66M, missing the average forecast of $84.33M by -61.27%. Lastly, the company's EPS was $0.03, missing the average prediction of $-0.108 by -127.89%